BRAF and non-small cell lung carcinoma: Interestingly, similar to oncogenic B-RAF, activation of oncogenic K-rasG12D, the most frequent mutation found in human NSCLC, was shown to impair lung morphogenesis by up-regulating Ras/MAPK antagonist Sprouty-2 in the absence of apoptosis [30].